Top Story

Early thymic precursor immunophenotype does not affect T-cell ALL outcomes

December 18, 2014

Read the Perspective from Mats Heyman, MD, PhD

SAN FRANCISCO — Children with T-cell acute lymphoblastic leukemia achieved favorable 5-year EFS and OS outcomes regardless of whether they expressed the early thymic precursor immunophenotype, according to results of a phase 3 study presented at the ASH Annual Meeting and Exposition.

The presence of minimal residual disease in the bone marrow at day 29 after induction therapy or at the end of consolidation therapy were both associated with a poorer outcome; however, minimal residual disease in the peripheral blood at day 8 did not provide additional prognostic utility, results also showed.

Health Care Legislative and Regulatory Update

New year, new code: How to get paid for chronic care management in 2015, part 1

December 18, 2014
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s…
Six chemotherapy cycles failed to improve outcomes in node-negative breast cancer Meeting News Coverage

Six chemotherapy cycles failed to improve outcomes in node-negative breast cancer

December 18, 2014
SAN ANTONIO — Patients with node-negative breast cancer who received six cycles of 5-fluorouracil, epirubicin and cyclophosphamide experienced similar DFS and OS as…
thumbnail for video 3949008667001 Meeting News CoverageVideo

Data show encouraging advances in treatment of AML

December 17, 2014
SAN FRANCISCO – According to preliminary data presented at the ASH Annual Meeting and Exposition, FLT3 inhibitors have been shown to have a dramatic, positive…
In the Journals

More studies urged in managing posttreatment fatigue in thyroid cancer

December 17, 2014
A paucity of reliable trials exists to guide evidence-based management of posttreatment fatigue in thyroid cancer survivors, according to a systematic review published…
More News Headlines »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
IBIS-I: Tamoxifen provides long-term protection for women at high risk for breast cancer

IBIS-I: Tamoxifen provides long-term protection for women at high risk for breast cancer

December 12, 2014
SAN ANTONIO — Erin W. Hofstatter, MD, director of the Breast Cancer Genetics and Prevention Program at Yale…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
morganatic-roan